Today: 20 March 2026
Browse Category

NASDAQ:REDD 30 December 2025 - 9 February 2026

Reddit stock rebounds in New York as analysts reset targets after earnings swing

Reddit stock rebounds in New York as analysts reset targets after earnings swing

Reddit shares rose 2% to $142.68 by late morning after last week’s post-earnings drop. Analyst price targets shifted, with Truist raising its target to $275 and Piper Sandler cutting to $205. Investors focused on user growth and ad momentum, while Reddit forecast Q1 revenue of $595 million to $605 million. The stock traded between $137.09 and $145.75 in early action.
Reddit stock slides after-hours as ‘mixed’ ad checks sting, Digg reboot adds fresh noise

Reddit stock slides after-hours as ‘mixed’ ad checks sting, Digg reboot adds fresh noise

Reddit shares fell 9.4% to $228.75 in after-hours trading Thursday after RBC flagged weak ad conversion rates and mixed demand from small-business agencies. CFO Andrew Vollero sold nearly $1.04 million in stock this week under a pre-arranged plan. Reddit will report Q4 earnings on Feb. 5. Digg relaunched in open beta Wednesday, led by Kevin Rose and Reddit co-founder Alexis Ohanian.
16 January 2026

Stock Market Today

  • Centene Launches Community Programs Amid Depressed Stock Price: What Investors Should Know
    March 20, 2026, 6:30 AM EDT. Centene Corp subsidiaries have initiated community-focused programs targeting behavioral health, job training, housing support, and diabetes care, aiming to assist underserved populations across major U.S. markets. These efforts come as Centene shares (NYSE:CNC) remain under pressure, with a recent price of $35.57, down 13.7% in the past month and 40.3% over one year. Investors should monitor these initiatives closely for insights into Centene's regulatory relations and potential impact on medical loss ratios and membership retention. Despite current headwinds, the stock trades nearly 17% below analyst targets and is marked as undervalued by Simply Wall St. Key risks include rising costs without clear reimbursement or measurable health outcomes.
Go toTop